Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Keyword Connections

myeloid
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
164
1 Prognostic impact of low allelic ratio FLT3- ITD and NPM1 mutation in acute myeloid leukemia
2 Treating Genetic Disorders Using State-Of-The-Art Technology
3 Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia
4 Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse
5 Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis
6 Hepatic candidiasis: an increasing problem in immunocompromised patients
7 Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia
8 A quantitative proteomic analysis of cofilin phosphorylation in myeloid cells and its modulation using the LIM kinase inhibitor Pyr1.
9 Utility of presepsin, soluble triggering receptor expressed on myeloid cells-1, and neutrophil CD64 for early detection of neonatal sepsis
10 Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
11 Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
12 Utility of presepsin, soluble triggering receptor expressed on myeloid cells-1, and neutrophil CD64 for early detection of neonatal sepsis
13 Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
14 [Precision medicine for acute myeloid leukemia based on genomic profiling].
15 CB2 receptor deletion on myeloid cells enhanced mechanical allodynia in a mouse model of neuropathic pain
16 Septic shock during platelet transfusion in a patient with acute myeloid leukaemia.
17 Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta-analysis.
18 New drugs approved for acute myeloid leukemia (AML) in 2018.
19 20-Cyclopropyl-cholecalciferol vitamin D<inf>3</inf>analogs: A unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines
20 Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
21 Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths.
22 Epithelial expression of an interstitial lung disease–associated mutation in surfactant protein-C modulates recruitment and activation of key myeloid cell populations in mice
23 Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.
24 Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.
25 The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.
26 Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.
27 Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.
28 Ligand-induced IFNGR1 down-regulation calibrates myeloid cell IFNγ responsiveness.
29 [Acute myeloid leukemia with sudden onset bilateral lower extremity paralysis caused by disseminated mucormycosis following unrelated bone marrow transplantation].
30 Prophylactic Measures During Induction for Acute Myeloid Leukemia.
31 Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.
32 The future of epigenetic therapy: CPI-0610 for the treatment of myeloidfibrosis.
33 Inflammation via myeloid differentiation primary response gene 88 signaling mediates the fibrotic response to implantable synthetic poly(ethylene glycol) hydrogels.
34 Antiproliferative and Immunoregulatory Effects of Azelaic Acid Against Acute Myeloid Leukemia the Activation of Notch Signaling Pathway.
35 In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells.
36 Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.
37 Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia.
38 The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.
39 The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China.
40 Knockdown of serine/threonine-protein kinase 24 promotes tumorigenesis and myeloid-derived suppressor cell expansion in an orthotopic immunocompetent gastric cancer animal model.
41 Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
42 A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.
43 Assessment of response to imatinib therapy in patients with chronic myeloid leukemia with e13a2 and e14a2 transcripts of BCR/ABL1 gene.
44 Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
45 Vitamin B6 Addiction in Acute Myeloid Leukemia.
46 Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia (Nature Communications, (2019), 10, 1, (5351), 10.1038/s41467-019-13259-2)
47 [The impact of KIT and other concomitant gene mutations on the prognoses of patients with core-binding factor acute myeloid leukemia].
48 Control of Metastases via Myeloid CD39 and NK Cell Effector Function.
49 Plaque-associated myeloid cells derive from resident microglia in an Alzheimer's disease model
50 Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial.
51 Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy.
52 MicroRNAs expression profiles as biomarkers and therapeutic tools in Turkish patients with chronic myeloid leukemia.
53 Styryl Quinazolinones as Potential Inducers of Myeloid Differentiation via Upregulation of C/EBPα.
54 Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias
55 Clinical classification of 109 chronic myeloid leukemia cases and its correlation with Ph chromosomes
56 Clinical classification of 109 chronic myeloid leukemia cases and its correlation with Ph chromosomes.
57 Listeria monocytogenes Meningitis Following Imatinib Mesylate-Induced Monocytopenia in a Patient with Chronic Myeloid Leukemia
58 Primary cerebellar extramedullary myeloid cell tumor mimicking oligodendroglioma
59 In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2′-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase ( dck ) gene
60 Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
61 Unusual relapse of acute myeloid leukemia: granulocytic sarcoma presenting as an acute paraplegia
62 Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience
63 Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor
64 the intriguing occurrence of acute myeloid leukemia in a case of acute lymphoblastic leukemia:report of two cases
65 normal hematopoietic progenitor subsets have distinct reactive oxygen species, bcl2 and cell-cycle profiles that are decoupled from maturation in acute myeloid leukemia.
66 the expansion of myeloid-derived suppressor cells is associated with joint inflammation in rheumatic patients with arthritis
67 leucemia mielóide crônica: novas drogas em desenvolvimento chronic myeloid leukemia: development of new drugs
68 generation and characterization of a human induced pluripotent stem (ips) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the calr 52 bp deletion and the asxl1 p.r693x mutation
69 a case of chronic myeloid leukemia in a patient of double heterozygous hb-e beta thalassemia
70 a case of acute myeloid leukemia presenting with deep venous thrombosis
71 trisomy of chromosome 8 in ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of bcr-abl tyrosinkinases
72 the partial duplication of the 5′ segment of kmt2a revealed kmt2a-mllt10 rearrangement in a boy with acute myeloid leukemia
73 multicentric extramedullary myeloid tumor
74 ontogeny of myeloid cells
75 a rare presentation of chronic myeloid leukemia blast crisis
76 selection of tumor-specific cytotoxic t lymphocytes in acute myeloid leukemia patients through the identification of t-cells capable to establish stable interactions with the leukemic cells: “doublet technology”
77 cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells
78 auricular oedema and dyshidrotic eczema in a patient with acute myeloid leukaemia treated with cytarabine
79 development and targeted use of nilotinib in chronic myeloid leukemia
80 adherence to treatment with imatinib in chronic myeloid leukemia: a study of the first decade of responses obtained at a brazilian hospital
81 two distinct myeloid subsets at the term human fetal–maternal interface
82 treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
83 azelaic acid exerts antileukemic activity in acute myeloid leukemia
84 leishmania hijacks myeloid cells for immune escape
85 vertigo as the first sign of chronic myeloid leukemia: a case report and literature review
86 response and survival in acute myeloid leukemia patients not candidates to transplantation treated with azacitidine versus palliative treatment: a retrospective study
87 evolution of our understanding of myeloid regulatory cells: from mdscs to mregs
88 metilação e expressão do gene junb na leucemia mieloide crônica junb methylation and expression in chronic myeloid leukemia
89 modeling myeloid malignancies using zebrafish
90 the relationship between clinical feature, complex immunophenotype, chromosome karyotype, and outcome of patients with acute myeloid leukemia in china
91 complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with cisplatin and radiotherapy
92 monitoramento de doença residual mínima em leucemia mielóide crônica por pcr em tempo real monitoring minimal residual disease in chronic myeloid leukemia by real time pcr
93 targeting bcl2 family in human myeloid dendritic cells: a challenge to cure diseases with chronic inflammations associated with bone loss
94 distinct functional programs in fetal t and myeloid lineages
95 an unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and runx1–mecom fusion transcripts
96 a paraneoplastic syndrome characterized by extremity swelling with associated inflammatory infiltrate heralds aggressive transformation of myelodysplastic syndromes/myeloproliferative neoplasms to acute myeloid leukemia: a case series
97 importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance
98 acute myeloid leukemia in turkish children with fanconi anemia. one center experience in the period between 1964-1995
99 secondary leukemia in a non-hodgkin's lymphoma patient presenting as myeloid sarcoma of the breast
100 the impact of atra on shaping human myeloid cell responses to epithelial cell-derived stimuli and on t-lymphocyte polarization
101 m-csf and gm-csf regulation of stat5 activation and dna binding in myeloid cell differentiation is disrupted in nonobese diabetic mice